Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis.

Su X, Gao Y, Yang R. · 2022

Read Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis. by Su X, Gao Y, Yang R. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9330295.txt.

Introduction

Su and co-authors review how gut microbe products of tryptophan keep the body in balance. Tryptophan is an essential amino acid from food proteins. Gut microbes turn it into a family of indole compounds. These products act on gut lining, immunity, and organs far away.

The review explains how the metabolites are made and controlled. They push immune cells toward calm, regulatory types. They also spur cells that release IL-22, a gut-protecting signal. Effects run through the aryl hydrocarbon receptor on many immune cells. Disease links span bowel inflammation, tumors, obesity, liver scarring, and brain disorders. A high kynurenine ratio marks poor outlook after some cancer immunotherapy. The authors see treatment promise in tuning this pathway.

Catalog record

CREATORSu X, Gao Y, Yang R.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9330295

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis By Xiaomin Su, Yunhuan Gao, Rongcun Yang, Alexander E. Kalyuzhny Published in: Cells DOI: 10.3390/cells11152296 ABSTRACT Tryptophan is an essential amino acid from dietary proteins. It can be metabolized into different metabolites in both the gut microbiota and tissue cells. Tryptophan metabolites such as indole-3-lactate (ILA), indole-3-acrylate (IAC), indole-3-propionate (IPA), indole-3-aldehyde (IAID), indoleacetic acid (IAA), indole-3-acetaldehyde and Kyn can be produced by intestinal microorganisms through direct Trp transformation and also, partly, the kynurenine (Kyn) pathway. These metabolites play a critical role in maintaining the homeostasis of the gut and systematic immunity and also potentially affect the occurrence and development of diseases such as inflammatory bowel diseases, tumors, obesity and metabolic syndrome, diseases in the nervous system, infectious diseases, vascular inflammation and cardiovascular diseases and hepatic fibrosis. They can not only promote the differentiation and function of anti-inflammatory macrophages, Treg cells, CD4+CD8αα+ regulatory cells, IL-10+ and/or IL-35+B regulatory cells but also IL-22-producing innate lymphoid cells 3 (ILC3), which are involved in maintaining the gut mucosal homeostasis. These findings have important consequences in the immunotherapy against tumor and other immune-associated diseases. We will summarize here the recent advances in understanding the generation and regulation of tryptophan metabolites in the gut microbiota, the role of gut microbiota-derived tryptophan metabolites in different immune cells, the occurrence and development of diseases and immunotherapy against immune-associated diseases. 1. INTRODUCTION Tryptophan (Trp) is an essential amino acid, which can be naturally provided by dietary proteins such as poultry, milk, tuna, fish, cheese, bread, oats, prunes, chocolate and peanuts. It is a biosynthetic precursor of a large number of metabolites [1]. Trp metabolites can be derived from the direct transformation of Trp by intestinal microorganisms, such as indole, tryptamine, indole ethanol (IE), indolepropionic acid (IPA), indolelactic acid (ILA), indoleacetic acid (IAA), skatole, indolealdehyde (IAld) and indoleacrylic acid (IA) [2,3,4,5,6], and from the Kyn pathway, such as Kyn and 3-hydroxyanthranilic acid (3-HAA) [1,7]. These metabolites play a critical role in maintaining the epithelial cell structure and function [8], gastrointestinal motility [9] and insulin secretion of pancreatic β cells [10]. These Trp metabolites can also maintain the homeostasis and function of immune cells [11,12]. They activate signal pathways to control the differentiation and functions of immune cells through transcription factors such as the aryl hydrocarbon receptor (AhR), which is expressed in macrophages (Macs) [13], dendritic cells (DCs) [14], T cells [15], B cells [16], CD4+CD8αα+ lymphocytes [17] and innate lymphoid cells (ILCs) [18]. Trp metabolites also induce IL-22 production in T cells and promote the differentiation of IL-22-producing ILC3 cells. Gut microbiota-derived Trp metabolites are also related to many diseases, such as inflammatory bowel diseases, vascular inflammation and cardiovascular diseases, hepatic fibrosis, diseases in the nervous system, obesity and metabolic syndrome, infectious diseases and tumors. The recent progress in large-scale sequencing and mass spectrometry has further increased our understanding of the influence of the gut microbiota and its metabolites on the progression of tumors and the efficacy of immunotherapy on tumors. Their effects on stress-related depression, schizophrenia and Alzheimer’s and Parkinson’s diseases are widely known [19]. There are significant differences in some Trp metabolites and metabolic enzymes between patients and healthy volunteers, such as that patients with inflammatory bowel diseases (IBD) have lower levels of Trp in both their serum and feces than healthy subjects [20,21]. Trp metabolite Kyn is present in higher amounts in the plasma of advanced-stage cancer patients. Interestingly, Trp metabolites and their interacting ligands are also involved in tumor immunotherapy. A high-serum Kyn/Trp ratio is also correlated with a poor prognosis after a PD-1 blockade in lung cancer, melanoma and renal cell carcinomas [22]. We summarize the recent advances in understanding the generation and regulation of Trp metabolites in gut microbiota, the regulation of gut microbiota-derived Trp metabolites in the different immune cells and potential applications in immunotherapy against immune-associated diseases such as tumors. 2. TRP METABOLISM IN GUT MICROBIOTA 2.1. Trp Metabolism in Gut Microbiota Trp metabolism in the gut microbiota has been reviewed by multiple papers [1,23,24,25]. The degradation of dietary proteins leads to the release of Trp, which is converted into various metabolites by the gut microbiota, such as indole, indole-3-acid-acetic (IAA), indole-3-propionic acid (IPA), indoleacrylic acid (IA), indole-3-aldehyde (IAld), tryptamine, indoleethanol (IE), indole-3-acetaldehyde (IAAld) and 3-methylindole (skatole), or catalyzed to produce Kyn and downstream metabolites such as 3-hydroxyanthranilic acid (3-HAA) and 3-hydroxykynurenine (3H-Kyn) [1,23,24] (Figure 1 and Table 1). Bacterial species possess different catalytic enzymes, whereas some bacteria can also cooperate with each other to generate Trp metabolites. Bacterial species such as Bacteroides ovatus, Clostridium limosum, Enterococcus faecalis and Escherichia coli are able to convert Trp into indole [23,26]. The oxidative and reductive pathways in Clostridium sporogenes lead to the production of IAA and IPA [20,27]. Clostridium bartlettii and Bifidobacterium spp. produce ILA and IAA [28]. Peptostreptococcus spp. convert Trp to IA and IPA [29]. IAld is also generated by Firmicutes phylum, such as Lactobacillus (L). reuteri, L. johnsonii, L. acidophilus and L. murinus, via the aromatic amino acid aminotransferase (ArAT) and an indolelactic acid dehydrogenase (ILDH) [17]. Skatoles are generated by the decarboxylation of IAA by Bacteroides spp. and Clostridium spp. [5,28]. Ruminococcus gnavus converts Trp into tryptamine by a Trp decarboxylase enzyme [30]. Trp-metabolizing pathways also exist in some members of the human gut microbiota, such as Clostridium sporogenes, which can decarboxylate Trp to the neurotransmitter tryptamine [30]. In addition, several intestinal bacteria encode enzymes homologous to those of the eukaryotic Kyn pathway. These enzymes can produce Kyn and downstream metabolites such as 3-hydroxyanthranilic acid [7]. However, it will be necessary for understanding which kind of gut microbiota produce Trp metabolites [24], more bacterial strains with a catalytic capacity against Trp remain to be identified. This will be beneficial for the design of targeted strategies to control Trp metabolite production. 2.2. Regulation of Trp Metabolism in Gut Microbiota Recent studies showed that Trp metabolism in the gut microbiota can be regulated by multiple factors such as natural substances and chemical drugs (Figure 1). Ginsenoside Rg1 could increase the levels of Trp metabolites in the serum, including indole-3-carboxaldehyde, indole-3-lactic acid, 3-indolepropionic acid and niacinamide [43]. In mice with high-fat diet-induced obesity, ginsenoside Rb1 significantly altered the gut microbiota composition and serum Trp [44]. Fucose increased the abundance of Trp-producing E. coli and normalized the blood Trp levels [45]. Fructooligosaccharides (FOS) modulated the gut microbiome profiles, such as an increase in the abundance of Ruminococcacere (phylum level) and a decrease in the abundance of Akkermansiaceae (family level) and Verrucomicrobia (phylum level), and significantly increased the levels of Trp and 5-hydroxytryptamine (5-HT) [46]. The ginseng polysaccharides decreased L-kynurenine, as well as the ratio of Kyn/Trp [47]. The Fuzhuan brick tea polysaccharide contributed to the proliferation of beneficial microbiota, such as Lactobacillus and Akkermansia, and altered the Trp metabolism and elevated the fecal contents of IAld and IAA [48]. Flammulina velutipes polysaccharides (FVPs) also changed the composition of the gut microbiota, which affected the Trp metabolism [49]. The low abundance of Escherichia-Shigella, Dubosiella and Allobaculum, along with the enrichment of Muribaculaceae_unclassified, Ralstonia and Rikenellaceae_RC9_gut_group in the gut, which could result in higher Trp metabolite levels, could be detected in yellow wine polyphenolic compound-treated rats [50].

Read the complete text